RSS

Niemann-Pick Type C (NP-C)

Biopharmaceutical company, Sucampo Pharmaceuticals, has announced the publication of a study in PLOS ONE that confirms the composition of VTS-270, which is currently under investigation for the treatment of Niemann-Pick Disease Type C1 (NPC-1). more

News

Boyds has joined CTD Holdings’ International Clinical Program team, along with Aptus Clinical and KJC Statistics, to develop orphan drug Trappsol Cyclo with Accenture. more

News